An interventional study of Pulse Electromagnetic Field and Sham Pulse Electromagnetic Field in Knee Osteoarthritis and Knee Pain Chronic, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-20.
Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong — 9 open to participants now, 10 under way, none of them phase 3. Osteoarthritis, Knee · Chinese University of Hong Kong.
Among the 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong, this one is the 5th largest by planned enrollment of the 16 interventional ones that give a count, is one of 5 that started in 2022, is one of 15 with no phase, and was the 10th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →9 of the 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:
Chinese University of Hong Kong · Sites in Hong Kong
Ages 50+
Chinese University of Hong Kong · Sites in Hong Kong
Ages 50–100
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18+
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18+ · Healthy volunteers
Chinese University of Hong Kong · Sites in Hong Kong
Ages 45+
By country, each count listing its studies:
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 50 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 5 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 64 across the 16 interventional studies, 85 across the 4 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Chinese University of Hong Kong is the lead sponsor of 1,458 studies on the registry; 478 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
2 of the studies in Osteoarthritis, Knee by Chinese University of Hong Kong that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06838663Chinese University of Hong KongRobotic-Assisted Total Knee Arthroplasty: Cruciate-Retaining Versus Bi-Cruciate Stabilized | 2027-06 |
| NCT07912333Chinese University of Hong KongWearable Device Guided Exercise for Patients on Total Knee Arthroplasty Wait-list | 2027-11-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Health care costs are increasing alarmingly, which will impose an overwhelming economic burden to an aging society like that of Hong Kong. For example, degenerative musculoskeletal disorders such as osteoarthritis (OA) present a grand challenge with its high prevalence (>40% in the elderly suffered from knee OA). OA is a debilitating progressive disease with typical symptoms such as acute pain causing loss of mobility Currently there is no cure for OA. Pharmacological treatment and new regenerative technologies such as stem cell therapy are actively being developed, but most of these options are very expensive per se, and side effects are not uncommon. Costeffectiveness is also a major consideration for devising new therapeutic modalities for OA.
There are emerging evidences showing that pulsed electromagnetic field (PEMF) can modulae mitochondrial activities for muscle gain. PEMF exposure on top of regular exercise training may promote muscle regeneration and tissue healing.
This study aims to conduct a double-blinded, randomized controlled trial to investigate the effect of PEMF treatment on knee pain in patients with knee OA. We hypothesize that PEMF treatment is effective to relief in pain and improve knee function in Knee OA subjects.
Based on the aim of this study, older adult patients (aged 50 or above) with knee OA with Kellgren-Lawrence grade 2-4 by X-ray, have sedentary lifestyle (Tegner activity level less or equal to 3), no acute knee injuries in past 12 months, no muscle strain in past 12 months and not degenerative joint disease in other joints except the involved knee.
To estimate the improvement of patients, isometric quadricep muscle strength, posture assessment, serum myokine level, serum vitamin D level and selfreported outcome with questionnaires will be performed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Pulse Electromagnetic Field
Device: Sham Pulse Electromagnetic Field
Subjects will receive PEMF treatment with the duration of 8 weeks, twice a week with total 16 treatment sessions and do the home-based exercise twice a week for 8 weeks.
Subjects will receive sham PEMF treatment with the duration of 8 weeks, twice a week with total 16 treatment sessions and do the home-based exercise twice a week for 8 weeks.
Change of Peak torque of Isometric muscle strength
The peak torque in kgf will be recorded with in 2 trials in the 5 seconds isometric muscle strength test.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
International Physical Activity Questionnaire
Consists of four items recording the subject's time of spending on physical activities during the past 7 days with a validated Chinese version of the quantitative physical activity questionnaire, and the physical activity level will be evaluated by Metabolic Equivalent of task(MET) per minute and classified as physical level with Low, Moderate or High.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Tegner activity score
This is an activity level scaled from 1 (low activity) to 10 (high activity).
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Short Form-36 questionnaires (SF-36)
This is a 36-item patient-reported questionnaire that covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Serum myokine evaluation
Phlebotomy (5ml) will be performed on the day before PEMF treatment, at 4- and 8- weeks after commencement of treatment, and at 8 months after the commencement of intervention. The serum will be prepared by centrifugation and kept in a -80o freezer until use. Quantitative analysis for myokines and proteins related to muscle metabolism will be performed by Human Myokine Magnetic Bead Panel (Millipore) with Bioplex-200 bead-based suspension assay system (LKSIHS core facilities), or enzyme-linked immunosorbent assay (ELISA) and report with pg/ml. These include Brain-derived neurotrophic factor (BDNF), Fibroblast growth factor-21 (FGF-21), Interleukin-6 (IL-6), IL-15, Irisin, Myostatin (MSTN)/GDF8, Insulin-like growth factor 1 (IGF-1), FGF-2, IL-8, Follistatin, Musclin, Myonectin, Decorin, Meteorinlike, Osteopontin, Secreted protein acidic and rich in cysteine (SPARC), Klotho, Procollagen type III Nterminal peptide (P3NP), and C- terminal of troponin T1 (TNNT1).
Time frame: pre PEMF treatment, 3-months, 6-months, and 12-months after the commencement of PEMF
The speed and rate of force development in 6 repetitions in chair stand test
The rate of force development will be determined as the mean slope of the rising force of the first force peak of each of the 2nd to the 6th repetition in the interval of 30-70% exerted peak force. Results are reported as the mean of the two fastest approved trials in body weight per second (BW/s).
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Change of centre of pressure with the position of double leg squat
The centre of pressure excursion range in the anterior-posterior direction in mm will be recored.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Change of centre of pressure with the position of static postural codition
The centre of pressure excursion range in the anterior-posterior direction in mm will be recored.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Change of centre of pressure with the position of dynamic postural codition
The centre of pressure excursion range in the anterior-posterior direction in mm will be recored.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Serum vitamin D level and vitamin D metabolites evaluation
Blood samples will be taken under non-fasting conditions. Serum / plasma obtained will be immediately stored at -80°C until analysis. Serum 25(OH) Vit-D assay: Serum 25(OH)Vit-D levels will be measured by commercial 25(OH) Vitamin D ELISA kit (Abcam ab213966) according to the manufacturer's instruction, providing the quantitative determination of 25(OH) Vitamin D3 and 25(OH) Vitamin D2. Sensitivity: 1.98 ng/ml (Range: 0.5 ng/ml - 1010 ng/ml).
Time frame: pre PEMF treatment, 3-months, 6-months, and 12-months after the commencement of PEMF
Visual Analogue Scale
The subjective measurement for chronic and acute pain will be recorded by the Visual Analogue Scale (VAS). VAS consists of a 10-cm line which represents the continuum between "painless" and "worst pain from 0 cm to 10 cm. The subject will be asked to draw a mark of it before and after each PEMF treatment session.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
Change of the scoring of Knee injury and Osteoarthritis Outcome Score
Consist of 42 items with 5 subscapes: pain, other symptoms, function in daily living (ADL), function in sport and recreation (Sport/Rec), and knee-related quality of life (QOL) from 0% to 100% where higher score indicate a better outcome in each subscape.
Time frame: pre PEMF treatment , 2-months, 3-months, 6-months, and 12-months after the commencement of PEMF
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — All IPD that underlie results in a publication.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: starting 6 months after publication
Access criteria: Journal reviewers
Started May 2022 (actual). Primary completion is estimated for Sep 2024, 28 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 28 months is above that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese University of Hong Kong →